|Articles|March 11, 2009

Bevacizumab for neovascular glaucoma

Intracameral Bevacizumab (Avastin) for Neovascular Glaucoma: A Pilot Study in 6 Patients

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Latest CME